David E. Kloecker

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Five-year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England.

Five-year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England.

Journal: Diabetes, obesity & metabolism

Published: November 07, 2024

Translating trial results into interpretable risk estimates: Systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.

Translating trial results into interpretable risk estimates: Systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: September 04, 2023

Effect of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on time to outcome in type 2 diabetes cardiorenal outcome trials.

Effect of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on time to outcome in type 2 diabetes cardiorenal outcome trials.

Journal: Diabetes & metabolic syndrome

Published: September 04, 2023

Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149-154.

Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149-154.

Journal: Diabetes

Published: July 20, 2023

The impact of COVID-19 lockdowns on the body mass index of people living with obesity: A UK retrospective cohort study using the UK Clinical Practice Research Datalink.

The impact of COVID-19 lockdowns on the body mass index of people living with obesity: A UK retrospective cohort study using the UK Clinical Practice Research Datalink.

Journal: Obesity research & clinical practice

Published: December 13, 2022

Intensive glucose control and recurrent cardiovascular events: 14-year follow-up investigation of the ACCORDION study.

Intensive glucose control and recurrent cardiovascular events: 14-year follow-up investigation of the ACCORDION study.

Journal: Diabetes/metabolism research and reviews

Published: April 21, 2022

Non-inferiority and clinical superiority of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes.

Non-inferiority and clinical superiority of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: January 19, 2022

Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank.

Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank.

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: August 25, 2021

Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation.

Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation.

Journal: European journal of public health

Published: March 21, 2021

Using observational data to prioritise COVID-19 vaccination strategies: opportunity or necessity?

Using observational data to prioritise COVID-19 vaccination strategies: opportunity or necessity?

Journal: Public health

Published: December 22, 2020

Association of working shifts, inside and outside of healthcare, with severe COVID-19: an observational study.

Association of working shifts, inside and outside of healthcare, with severe COVID-19: an observational study.

Journal: BMC public health

Published: December 22, 2020

Cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: The P value and beyond.

Cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: The P value and beyond.

Journal: Diabetes, obesity & metabolism

Published: November 25, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026